Literature DB >> 12898257

Impaired slow inactivation due to a polymorphism and substitutions of Ser-906 in the II-III loop of the human Nav1.4 channel.

Alexey Kuzmenkin1, Karin Jurkat-Rott, Frank Lehmann-Horn, Nenad Mitrovic.   

Abstract

The loop connecting domains II and III of the sodium channel alpha-subunit is not known to have a major effect on channel gating. Recently mutations in the II-III loop of various sodium channel isoforms have been reported to cause channelopathies suggesting the functional importance of this region. In the II-III loop of the skeletal muscle isoform Na(v)1.4, we found a Ser-to-Thr substitution at position 906 in 5% of patients with dyskalemic periodic paralysis but also in 4% of healthy human individuals. To investigate whether this position is important for channel gating, we characterized the following amino acids at 906 by whole-cell patch-clamp experiments: Gln, Ser, Thr, Cys, Pro, Val, ordered according to their hydrophobicity. All substitutions mainly affected slow inactivation. For example, Gln caused a +13-mV right-shift of the steady-state slow inactivation curve, and entry into slow inactivation was 6 times slower compared with Ser, leading to a destabilization of the slow inactivated state; in contrast, Val, at the other end of the hydrophobicity spectrum, shifted the steady-state slow inactivation curve by -6 mV and slowed the recovery from the slow inactivated state threefold compared with Ser, resulting in an enhancement of slow inactivation. Recovery from the slow inactivated state was also slowed by Pro, Cys and Thr. Our results suggest that (1) a benign polymorphism affects channel function, (2) the II-III loop is important for slow inactivation, and (3) the effects on slow inactivation may depend on the hydrophobicity of the residue at position 906.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898257     DOI: 10.1007/s00424-003-1137-5

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  36 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  Potentiation of rat brain sodium channel currents by PKA in Xenopus oocytes involves the I-II linker.

Authors:  R D Smith; A L Goldin
Journal:  Am J Physiol Cell Physiol       Date:  2000-04       Impact factor: 4.249

3.  Development of hydrophobicity parameters to analyze proteins which bear post- or cotranslational modifications.

Authors:  S D Black; D R Mould
Journal:  Anal Biochem       Date:  1991-02-15       Impact factor: 3.365

4.  Structural parts involved in activation and inactivation of the sodium channel.

Authors:  W Stühmer; F Conti; H Suzuki; X D Wang; M Noda; N Yahagi; H Kubo; S Numa
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Hydrophobicity of amino acid residues in globular proteins.

Authors:  G D Rose; A R Geselowitz; G J Lesser; R H Lee; M H Zehfus
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Phosphorylation at a single site in the rat brain sodium channel is necessary and sufficient for current reduction by protein kinase A.

Authors:  R D Smith; A L Goldin
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

8.  A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy.

Authors:  A Escayg; A Heils; B T MacDonald; K Haug; T Sander; M H Meisler
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

9.  Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.

Authors:  Tateki Fujiwara; Takashi Sugawara; Emi Mazaki-Miyazaki; Yukitoshi Takahashi; Katsuyuki Fukushima; Masako Watanabe; Keita Hara; Tateki Morikawa; Kazuichi Yagi; Kazuhiro Yamakawa; Yushi Inoue
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

10.  Mild muscular dystrophy due to a nonsense mutation in the LAMA2 gene resulting in exon skipping.

Authors:  C Di Blasi; Y He; L Morandi; F Cornelio; P Guicheney; M Mora
Journal:  Brain       Date:  2001-04       Impact factor: 13.501

View more
  12 in total

Review 1.  Muscle channelopathies and critical points in functional and genetic studies.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 2.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

3.  Rapid protein kinase C-dependent reduction of rat skeletal muscle voltage-gated sodium channels by ciliary neurotrophic factor.

Authors:  S Talon; M-A Giroux-Metges; J-P Pennec; C Guillet; H Gascan; M Gioux
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 5.  Sodium channelopathies of skeletal muscle result from gain or loss of function.

Authors:  Karin Jurkat-Rott; Boris Holzherr; Michael Fauler; Frank Lehmann-Horn
Journal:  Pflugers Arch       Date:  2010-03-17       Impact factor: 3.657

Review 6.  [Pharmacogenetics in anesthesia and intensive care medicine : Clinical and legal challenges exemplified by malignant hyperthermia].

Authors:  W Klingler; E Pfenninger
Journal:  Anaesthesist       Date:  2016-05       Impact factor: 1.041

7.  Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13).

Authors:  Karla P Figueroa; Michael F Waters; Vartan Garibyan; Thomas D Bird; Christopher M Gomez; Laura P W Ranum; Natali A Minassian; Diane M Papazian; Stefan M Pulst
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

8.  Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients.

Authors:  Marius Kuhn; Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-16       Impact factor: 10.154

9.  Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  J Neuromuscul Dis       Date:  2015-07-22

10.  Novel isoforms of the sodium channels Nav1.8 and Nav1.5 are produced by a conserved mechanism in mouse and rat.

Authors:  Niall C H Kerr; Fiona E Holmes; David Wynick
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.